Cost analysis of oral hypolipidemic agents available in India

Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market

“…5,6 Earlier studies have shown a wide variation in prices of the same drugs manufactured by different pharmaceutical companies. [7][8][9] As there is a paucity of data regarding the assessment of price variation among anxiolytic drugs, this study was planned to assess the price variation amongst different anxiolytic drugs available in Indian market.  The drug formulation being manufactured by only one pharmaceutical company or being manufactured by different pharmaceutical companies; however, in different strengths were excluded.…”

Assessment of Impact of ‘Drug Price Control Order 2013’ For Essential Medicines in India

“…87.10% of essential medicines were under price control in this study and 36 drugs (12.54%) were showing increment in drug prices (Table no1). Some of studies are available in India comparing the cost of the same drug sold under different brand names by different pharmaceutical companies where difference in the maximum and minimum price of the same drug formulation manufactured by different pharmaceutical companies and percentage variation in price was calculated [10] . But there is no similar study available to quantify inter-quarter comparisons (before and after DPCO 2013 implementation) to calculate percentage changes in drug costs.…”

Price analysis of antianginal drugs available in Indian market

“…10,11 Some previous price analysis studies of oral hypolipidemic drugs, antiepileptic drugs, oral fluoroquinolone antibiotics and anxiolytic drugs have also showed such a wide variation in prices in Indian market. [12][13][14][15] This study also highlights the wide variation in prices amongst antianginal drugs marketed in India.…”